Press Release:
Visualase To Be Awarded $2.1 Million For Prostate Cancer Research.
Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The precision and control of the Visualase technology has made possible the ablation of tissue in areas such as brain and prostate.
FDA Statement